These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 101569)

  • 1. Screening for mild hypertension: costs and benefits.
    Bryers F; Hawthorne VM
    J Epidemiol Community Health (1978); 1978 Sep; 32(3):171-4. PubMed ID: 101569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An economic appraisal of the benefits of screening for open spina bifida.
    Henderson JB
    Soc Sci Med; 1982; 16(5):545-60. PubMed ID: 6808668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models.
    Davis A; Smith P; Ferguson M; Stephens D; Gianopoulos I
    Health Technol Assess; 2007 Oct; 11(42):1-294. PubMed ID: 17927921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal costs and benefits.
    Torgerson DJ; Spencer A
    BMJ; 1996 Jan; 312(7022):35-6. PubMed ID: 8555859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.
    Boer R; de Koning H; Threlfall A; Warmerdam P; Street A; Friedman E; Woodman C
    BMJ; 1998 Aug; 317(7155):376-9. PubMed ID: 9694752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer screening; cost-effective in practice?
    De Koning HJ
    Eur J Radiol; 2000 Jan; 33(1):32-7. PubMed ID: 10674787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and benefits of cervical screening. I. The costs of the cervical screening programme.
    Waugh N; Smith I; Robertson A; Reid GS; Halkerston R; Grant A
    Cytopathology; 1996 Aug; 7(4):231-40. PubMed ID: 8853969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economics of mild hypertension programmes.
    Edgar MA; Schnieden H
    Soc Sci Med; 1989; 28(3):211-22. PubMed ID: 2493162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glaucoma screening clinic in general practice: prevalence of occult disease, and resource implications.
    Sheldrick JH; Sharp AJ
    Br J Gen Pract; 1994 Dec; 44(389):561-5. PubMed ID: 7677842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study.
    Wonderling D; McDermott C; Buxton M; Kinmonth AL; Pyke S; Thompson S; Wood D
    BMJ; 1996 May; 312(7041):1269-73. PubMed ID: 8634617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The national breast screening service: is it economically efficient?
    Torgerson DJ; Gosden T
    QJM; 1997 Jun; 90(6):423-5. PubMed ID: 9205681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.
    Danese MD; Powe NR; Sawin CT; Ladenson PW
    JAMA; 1996 Jul 24-31; 276(4):285-92. PubMed ID: 8656540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Planning for a possible national colorectal cancer screening programme.
    Garvican L
    J Med Screen; 1998; 5(4):187-94. PubMed ID: 9934649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health economics analysis of cervical cancer screening].
    Boncz I; Sebestyén A; Pál M; Sándor J; Ember I
    Orv Hetil; 2003 Apr; 144(15):713-7. PubMed ID: 12774432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical screening interval: costing the options in one health authority.
    Grant CM
    J Public Health Med; 1999 Jun; 21(2):140-4. PubMed ID: 10432241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
    Marks D; Thorogood M; Neil HA; Wonderling D; Humphries SE
    J Public Health Med; 2003 Mar; 25(1):47-52. PubMed ID: 12669918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.
    Hoerger TJ; Harris R; Hicks KA; Donahue K; Sorensen S; Engelgau M
    Ann Intern Med; 2004 May; 140(9):689-99. PubMed ID: 15126252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The detection and management of hypertension.
    Smith BH
    J Public Health Med; 1995 Dec; 17(4):490-1. PubMed ID: 8639352
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.